Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.52 |
| ▸ | CES2 | O00748 | 3/20 | 0.52 |
| ▸ | CES1 | P23141 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 3/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.46 |
| ▸ | PKM | P14618 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | ATM | Q13315 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL811028 | 0.84 | ALDH1A1 (0.50) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL1557844 | 0.83 | ALDH1A1 (0.48) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL2892447 | 0.83 | ALDH1A1 (0.48) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL1772947 | 0.82 | CES2 (0.47) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL5200457 | 0.79 | ALDH1A1 (0.45) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL5691184 | 0.78 | ALDH1A1 (0.59) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL1774091 | 0.78 | NPC1 (0.45) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL13536412 | 0.76 | ALDH1A1 (0.56) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL4269458 | 0.76 | ALDH1A1 (0.56) | ALDH1A1CES2CES1LMNASMN1; SMN2 | |
| SCHEMBL16358251 | 0.74 | ALDH1A1 (0.54) | ALDH1A1CES2CES1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 508 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250332824-A1 | ADHESIVE BACKED HYDROLYSIS-RESISTANT WINDOW FILM | GARWARE HI-TECH FILMS LIMITED (IN) | 2025-10-30 | — | — | US | claimed |
| US-20220143963-A1 | ADHESIVE BACKED HYDROLYSIS-RESISTANT WINDOW FILM | GARWARE HI-TECH FILMS LIMITED (IN) | 2022-05-12 | — | — | US | claimed |
| US-11292890-B2 | Curable resin composition and sealing material using same | NIPPON SHOKUBAI CO., LTD. (JP) | 2022-04-05 | — | — | US | claimed |
| US-20180134947-A1 | METHODS FOR TREATING HIGH TEMPERATURE SUBTERRANEAN FORMATIONS | SCHLUMBERGER TECHNOLOGY CORPORATION | 2018-05-17 | — | — | US | claimed |
| WO-2016159817-A1 | METHODS FOR TREATING HIGH TEMPERATURE SUBTERRANEAN FORMATIONS | SCHLUMBERGER CANADA LIMITED (CA) | 2016-10-06 | — | — | WO | claimed |
| US-9309356-B2 | Method for activating double metal cyanide catalysts for the production of polyether carbonate polyols | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-04-12 | — | — | US | claimed |
| EP-2734567-B1 | METHOD FOR ACTIVATING DOUBLE METAL CYANIDE CATALYSTS FOR THE PRODUCTION OF POLYETHER CARBONATE POLYOLS | BAYER IP GMBH (DE) | 2015-09-09 | — | — | EP | claimed |
| US-20140221602-A1 | METHOD FOR ACTIVATING DOUBLE METAL CYANIDE CATALYSTS FOR THE PRODUCTION OF POLYETHER CARBONATE POLYOLS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-08-07 | — | — | US | claimed |
| EP-2548905-A1 | Method for activating double metal cyanide catalysts to produce polyether polyols | Bayer MaterialScience AG (DE) | 2013-01-23 | — | — | EP | claimed |
| US-5834273-A | URICASE MODIFIED BY REACTING WITH POLYAMINO ACID CONTAINING GLUTAMIC ACID OR ASPARTIC ACID RESIDUES | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1998-11-10 | — | — | US | claimed |
| EP-4747282-A1 | ACTIVATABLE TYROSINE-PROTEIN KINASE MEMBRANE RECEPTOR (ROR) ANTIBODY-DRUG CONJUGATES AND USES THEREOF | Exelixis, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4747283-A1 | TYROSINE-PROTEIN KINASE MEMBRANE RECEPTOR 1 (ROR1) ANTIBODY-DRUG CONJUGATES AND USES THEREOF | Exelixis, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4746922-A2 | INTERLEUKIN-13 RECEPTOR SUBUNIT ALPHA-2 ANTIBODY-DRUG CONJUGATES AND USES THEREOF | Exelixis, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| US-12640420-B2 | Aluminum pouch film for secondary battery, and method for manufacturing same | SBTL ADVANCED MATERIALS CO., LTD. (KR) | 2026-05-26 | — | — | US | disclosed |
| US-20260083856-A1 | THIAZOLIDINE LINKERS FOR PROTEIN-DRUG CONJUGATES AND USES THEREOF | SCHERER TECHNOLOGIES LLC R P (US) | 2026-03-26 | — | — | US | disclosed |
| US-4871589-A | PRETREATMENT IMMERSION INTO ETHYLENIMINE, CARBODIIMIDE OR DERIVATIVES; BONDING STRENGTH | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 1989-10-03 | — | — | US | disclosed |
| US-4518802-A | IMMUNOSTIMULANT | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1985-05-21 | — | — | US | disclosed |
| US-4238391-A | AMIDATION OF BLEOMYCINIC ACID | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1980-12-09 | — | — | US | disclosed |
| US-4195018-A | CARCINOSTATIC ANTIBIOTICS | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1980-03-25 | — | — | US | disclosed |
| US-4164114-A | PET AND ANOTHER POLYESTER, RUBBER REINVORCEMENT, DURABILITY | Toyobo Petcord, Co., Ltd. (JP) | 1979-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083856-A1 | THIAZOLIDINE LINKERS FOR PROTEIN-DRUG CONJUGATES AND USES THEREOF | BRWD1, TMIGD3, TXNL1 | ALDH1A1 556/4885CES2 3204/4885CES1 2128/4885 |
| US-12640420-B2 | Aluminum pouch film for secondary battery, and method for manufacturing same | KDM2B, AFF2, MLN | ALDH1A1 1534/4885CES2 3907/4885CES1 4437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.